ArticleJournal of clinical medicine2022

Combining BeEAM with Brentuximab Vedotin for High-Dose Therapy in CD30 Positive Lymphomas before Autologous Transplantation-A Phase I Study.

Christian Rausch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.